Cita APA

Argiris, A., Lee, J. W., Stevenson, J., Sulecki, M. G., Hugec, V., Choong, N. W., . . . Schiller, J. H. (2017). Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3508). Ann Oncol.

Chicago Style Citation

Argiris, A., et al. "Phase II Randomized Trial of Carboplatin, Paclitaxel, Bevacizumab With or Without Cixutumumab (IMC-A12) in Patients With Advanced Non-squamous, Non-small-cell Lung Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E3508)." Ann Oncol 2017.

Cita MLA

Argiris, A., et al. "Phase II Randomized Trial of Carboplatin, Paclitaxel, Bevacizumab With or Without Cixutumumab (IMC-A12) in Patients With Advanced Non-squamous, Non-small-cell Lung Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E3508)." Ann Oncol 2017.